SCHEMBL14199028

SCHEMBL14199028

Cc1cccc2c1[nH]c(=O)n2Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.58
TLR7 Q9NYK1 5/20 0.56
DAO P14920 2/20 0.55
LMNA P02545 2/20 0.50
HTT P42858 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 2/20 0.48
ATM Q13315 1/20 0.48
C5AR1 P21730 1/20 0.48
HPGD P15428 1/20 0.48
ALDH1A1 P00352 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BRD4 O60885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4963836 0.84 HTR6 (0.58) HTR6TLR7DAOLMNAHTT
SCHEMBL3851027 0.83 HTR6 (0.59) HTR6TLR7DAOLMNAHTT
SCHEMBL3064318 0.82 DAO (0.60) HTR6DAOLMNAHTTMEN1
SCHEMBL23997220 0.81 HTR6 (0.58) HTR6TLR7DAOLMNAHTT
SCHEMBL30345083 0.81 HTR6 (0.58) HTR6TLR7DAOLMNAHTT
SCHEMBL30345091 0.79 C5AR1 (0.49) HTR6DAOLMNAHTTMEN1
SCHEMBL23997186 0.79 C5AR1 (0.49) HTR6DAOLMNAHTTMEN1
SCHEMBL6059432 0.78 DAO (0.59) DAOLMNAHTTMEN1KMT2A
SCHEMBL6060247 0.77 DAO (0.55) DAOLMNAHTTALDH1A1SMN1; SMN2
SCHEMBL3859399 0.77 DAO (0.53) HTR6TLR7DAOLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608627-B1 BICYCLIC ANILIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2008-05-07 EP disclosed
US-7202251-B2 Bicyclic anilide spirohydantoin CGRP receptor antagonists MERCK & CO., INC. (US) 2007-04-10 US disclosed
US-7202251-B2 Bicyclic anilide spirohydantoin CGRP receptor antagonists MERCK & CO., INC. (US) 2007-04-10 US disclosed